Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients (2016)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; SOUZA, CACILDA DA SILVA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1002/jcph.630
- Subjects: METABOLISMO; FARMACOCINÉTICA; PSORÍASE; ANTIDEPRESSIVOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Journal of Clinical Pharmacology
- ISSN: 0091-2700
- Volume/Número/Paginação/Ano: v. 56, n. 5, p. 567-575, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
GODOY, Ana Leonor Pardo Campos et al. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, v. 56, n. 5, p. 567-575, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.630. Acesso em: 19 abr. 2024. -
APA
Godoy, A. L. P. C., Rocha, A., Souza, C. da S., & Lanchote, V. L. (2016). Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, 56( 5), 567-575. doi:10.1002/jcph.630 -
NLM
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1002/jcph.630 -
Vancouver
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1002/jcph.630 - Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
- Detection of allopurinol and oxypurinol in canine urine by HPLC/MS-MS: focus on veterinary clinical pharmacokinetics
- Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers
- UPLC-MS/MS method for gemfibrozil determination in plasma with application to a pharmacokinetic study in healthy Brazilian volunteers
- Clinical treatment for hepatitis C reverses CYP2C19 inhibition
- Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta]
- Enantiosseletividade na farmacocinética da fluvastatina em ratos espontaneamente hipertensos e/ou com diabetes mellitus experimental
- No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients
- Enantiosseletividade no metabolismo do citalopram associado a inibidores do CYP: estudos clínico e experimental
Informações sobre o DOI: 10.1002/jcph.630 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
